Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    April 2021
  1. BAGWELL AK, Sutton TL, Gardiner S, Johnson N, et al
    Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.
    Am J Surg. 2021 Apr 1. pii: S0002-9610(21)00218.
    PubMed     Abstract available


    March 2021
  2. KAPUR H, Warburton R, Pao JS, Dingee C, et al
    Decreasing contralateral prophylactic mastectomy rates in average-risk women with unilateral breast cancer.
    Am J Surg. 2021 Mar 24. pii: S0002-9610(21)00175.
    PubMed     Abstract available


  3. LOVRICS O, Butt J, Lee Y, Lovrics P, et al
    The effect of bariatric surgery on breast cancer incidence and characteristics: A meta-analysis and systematic review.
    Am J Surg. 2021 Mar 18. pii: S0002-9610(21)00151.
    PubMed     Abstract available


    January 2021
  4. LADIPO OL, Ren Y, Caddell KB, Sampathkumar A, et al
    Does treatment sequence affect outcomes in patients with metaplastic breast cancer?
    Am J Surg. 2021 Jan 18. pii: S0002-9610(21)00005.
    PubMed     Abstract available


  5. HUYNH V, Tevis S
    Surgical management of invasive lobular carcinoma: Is less more?
    Am J Surg. 2021;221:30-31.
    PubMed    


  6. ABEL MK, Brabham CE, Guo R, Fahrner-Scott K, et al
    Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.
    Am J Surg. 2021;221:32-36.
    PubMed     Abstract available


    December 2020
  7. SAMMAN S, Cornacchi SD, Foster G, Thabane L, et al
    A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer.
    Am J Surg. 2020 Dec 25. pii: S0002-9610(20)30807.
    PubMed     Abstract available


  8. THOMPSON JL, Wright GP
    The role of breast MRI in newly diagnosed breast cancer: An evidence-based review.
    Am J Surg. 2020 Dec 9. pii: S0002-9610(20)30796.
    PubMed     Abstract available


  9. COLLINS PM, Brennan MJ, Elliott JA, Abd Elwahab S, et al
    Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome.
    Am J Surg. 2020 Dec 9. pii: S0002-9610(20)30776.
    PubMed     Abstract available


  10. LAYEEQUR RAHMAN R, Puckett Y, Habrawi Z, Crawford S, et al
    A decade of intraoperative ultrasound guided breast conservation for margin negative resection - Radioactive, and magnetic, and Infrared Oh My....
    Am J Surg. 2020;220:1410-1416.
    PubMed     Abstract available


  11. HAMMOND JB, Han GR, Cronin PA, Kosiorek HE, et al
    Exploring the Effect of Post-mastectomy complications on 5-year survival.
    Am J Surg. 2020;220:1422-1427.
    PubMed     Abstract available


    November 2020
  12. ELSHERIF AS, Tu C, Valente SA
    Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era.
    Am J Surg. 2020 Nov 9. pii: S0002-9610(20)30735.
    PubMed     Abstract available


  13. LAGENDIJK M, Desantis S, Nakhlis F, Duggan M, et al
    Impact of surgical complications on patient reported outcomes (PROs) following nipple sparing mastectomy.
    Am J Surg. 2020;220:1230-1234.
    PubMed     Abstract available


  14. CULLOM ME, Amin AL, Balanoff CR, Wagner JL, et al
    Evaluation of breast surgical oncology complications after single agent versus dual agent HER2 targeted neoadjuvant chemotherapy.
    Am J Surg. 2020;220:1225-1229.
    PubMed     Abstract available


    October 2020
  15. RUIZ J, Maldonado G, Ablah E, Okut H, et al
    Could lymph node evaluation be eliminated in nearly 50% of women with early stage ER/PR positive breast cancer?
    Am J Surg. 2020 Oct 6. pii: S0002-9610(20)30614.
    PubMed     Abstract available


    September 2020
  16. GENCO IS, Tugertimur B, Manolas PA, Hasanovic A, et al
    Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
    Am J Surg. 2020;220:677-681.
    PubMed     Abstract available


  17. JAMES TA, Palis B, McCabe R, Pardo JA, et al
    Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.
    Am J Surg. 2020;220:654-659.
    PubMed     Abstract available


    August 2020
  18. HABRAWI Z, Melkus MW, Khan S, Henderson J, et al
    Cryoablation: A promising non-operative therapy for low-risk breast cancer.
    Am J Surg. 2020 Aug 1. pii: S0002-9610(20)30482.
    PubMed     Abstract available


  19. FRANCESCHINI G, Masetti R
    Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery.
    Am J Surg. 2020;220:393-394.
    PubMed     Abstract available


  20. KOSASIH S, Tayeh S, Mokbel K, Kasem A, et al
    Is oncoplastic breast conserving surgery oncologically safe? A meta-analysis of 18,103 patients.
    Am J Surg. 2020;220:385-392.
    PubMed     Abstract available


    July 2020
  21. KENNEDY GT, Hill CM, Huang Y, So A, et al
    Enhanced recovery after surgery (ERAS) protocol reduces perioperative narcotic requirement and length of stay in patients undergoing mastectomy with implant-based reconstruction.
    Am J Surg. 2020;220:147-152.
    PubMed     Abstract available


    June 2020
  22. THEISS LM, Chu DI
    Invited commentary on "Delving deeper into disparity: The impact of health literacy on the surgical care of breast cancer patients".
    Am J Surg. 2020 Jun 11. pii: S0002-9610(20)30361.
    PubMed    


  23. HUANG J, Chagpar A
    Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Am J Surg. 2020;219:1036-1038.
    PubMed     Abstract available


    May 2020
  24. PORTELLI TREMONT JN, Downs-Canner S, Maduekwe U
    Delving deeper into disparity: The impact of health literacy on the surgical care of breast cancer patients.
    Am J Surg. 2020 May 12. pii: S0002-9610(20)30266.
    PubMed     Abstract available


  25. WEN B, Mousadoust D, Warburton R, Pao JS, et al
    Phyllodes tumours of the breast: Outcomes and recurrence after excision.
    Am J Surg. 2020;219:790-794.
    PubMed     Abstract available


    April 2020
  26. MACFIE R, Aks C, Panwala K, Johnson N, et al
    Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer.
    Am J Surg. 2020 Apr 30. pii: S0002-9610(20)30220.
    PubMed     Abstract available


  27. BAYARD S, Susick L, Kyei I, Chen Y, et al
    Brief report: Global health initiatives and breast oncology capacity-building in Africa.
    Am J Surg. 2020;219:563-565.
    PubMed     Abstract available


  28. WIENS N, Hoffman DI, Huang CY, Nayak A, et al
    Clinical characteristics and outcomes of benign, atypical, and malignant breast adenomyoepithelioma: a single institution's experience.
    Am J Surg. 2020;219:651-654.
    PubMed     Abstract available


    March 2020
  29. SUTTON TL, Johnson N, Schlitt A, Gardiner SK, et al
    Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates.
    Am J Surg. 2020 Mar 10. pii: S0002-9610(20)30146.
    PubMed     Abstract available


  30. BALISKI C, Hamm J
    Does receipt of preference sensitive care impact patient reported outcomes following breast cancer surgery?
    Am J Surg. 2020 Mar 10. pii: S0002-9610(20)30145.
    PubMed     Abstract available


  31. SUTTON TL, Johnson N, Garreau JR
    Adequate sentinel node harvest is associated with low false negative rate in breast cancer managed with neoadjuvant chemotherapy and targeted axillary dissection.
    Am J Surg. 2020 Mar 10. pii: S0002-9610(20)30154.
    PubMed     Abstract available


  32. CUI X, Zhu C, Chen P, Qu M, et al
    Effect of pectoral nerve block type II under general anesthesia on the immune function of patients with breast cancer.
    Am J Surg. 2020 Mar 8. pii: S0002-9610(20)30150.
    PubMed     Abstract available


    February 2020
  33. LIU C, Cheifetz R, Brown C, Nichol A, et al
    Do surgeons convey all the details? A provincial assessment of operative reporting for breast cancer.
    Am J Surg. 2020 Feb 29. pii: S0002-9610(20)30134.
    PubMed     Abstract available


  34. FENG Y, He XG, Zhou CM, Zhang QY, et al
    Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study.
    Am J Surg. 2020 Feb 28. pii: S0002-9610(20)30125.
    PubMed     Abstract available


  35. GOONAWARDENA J, Yong C, Law M
    Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis.
    Am J Surg. 2020 Feb 7. pii: S0002-9610(20)30069.
    PubMed     Abstract available


    January 2020
  36. CHA J, McKevitt E, Pao JS, Dingee C, et al
    Access to surgery following centralization of breast cancer surgical consultations.
    Am J Surg. 2020 Jan 31. pii: S0002-9610(20)30055.
    PubMed     Abstract available


  37. SROUR MK, Lee M, Walcott-Sapp S, Kim S, et al
    Thirty-day postoperative morbidity in patients with breast cancer following neoadjuvant chemotherapy.
    Am J Surg. 2020 Jan 22. pii: S0002-9610(20)30035.
    PubMed     Abstract available


    December 2019
  38. AGBORBESONG O, Helmer SD, Reyes J, Strader LA, et al
    Breast cancer treatment in the elderly: Do treatment plans that do not conform to NCCN recommendations lead to worse outcomes?
    Am J Surg. 2019 Dec 5. pii: S0002-9610(19)31558.
    PubMed     Abstract available


  39. HANGGE PT, Jogerst K, Mohsen A, Kosiorek H, et al
    Making an informed choice: Which breast reconstruction type has the lowest complication rate?
    Am J Surg. 2019;218:1040-1045.
    PubMed     Abstract available


    November 2019
  40. TSAI C, Zhao B, Chan T, Blair SL, et al
    Treatment for occult breast cancer: A propensity score analysis of the National Cancer Database.
    Am J Surg. 2019 Nov 11. pii: S0002-9610(19)31361.
    PubMed     Abstract available


  41. CROWN A, Rocha FG, Grumley JW
    Intraoperative radiation therapy in early-stage breast cancer: Presence of lobular features is not associated with increased rate of requiring additional therapy.
    Am J Surg. 2019 Nov 11. pii: S0002-9610(19)31293.
    PubMed     Abstract available


  42. BREIT C, Ablah E, Ward M, Okut H, et al
    Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
    Am J Surg. 2019 Nov 7. pii: S0002-9610(19)31492.
    PubMed    


    October 2019
  43. BREIT C, Ablah E, Ward M, Okut H, et al
    Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
    Am J Surg. 2019 Oct 11. pii: S0002-9610(19)30840.
    PubMed     Abstract available


  44. NAYYAR A, Strassle PD, Reddy KG, Jameison DI, et al
    Variations in the utilization of immediate post-mastectomy breast reconstruction.
    Am J Surg. 2019;218:712-715.
    PubMed     Abstract available


    August 2019
  45. CALDERON E, Webb C, Kosiorek HE, Richard J Gray MD, et al
    Are we choosing wisely in elderly females with breast cancer?
    Am J Surg. 2019 Aug 10. pii: S0002-9610(19)30354.
    PubMed     Abstract available


    July 2019
  46. KILLELEA BK, Gallagher EJ, Feldman SM, Port E, et al
    The effect of modifiable risk factors on breast cancer aggressiveness among black and white women.
    Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30187.
    PubMed     Abstract available


  47. PLICHTA JK, Thomas SM, Sergesketter AR, Greenup RA, et al
    Clinical and pathological stage discordance among 433,514 breast cancer patients.
    Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30099.
    PubMed     Abstract available


  48. BROMAN K, Sun W, Zhou JM, Fridley B, et al
    Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer.
    Am J Surg. 2019 Jul 17. pii: S0002-9610(19)30270.
    PubMed     Abstract available


    June 2019
  49. JAMES TA, Kasumova G, Alapati A, Mamtani A, et al
    Unplanned readmissions following breast cancer surgery.
    Am J Surg. 2019 Jun 20. pii: S0002-9610(19)30436.
    PubMed     Abstract available


  50. RANA S, Naik A, Pillai S, Vetto J, et al
    Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program.
    Am J Surg. 2019 Jun 18. pii: S0002-9610(19)30332.
    PubMed     Abstract available


    April 2019
  51. JAY M, Creelman B, Baliski C
    Patient reported outcomes associated with surgical intervention for breast cancer.
    Am J Surg. 2019 Apr 17. pii: S0002-9610(18)31307.
    PubMed     Abstract available


    March 2019

  52. Effect of wound complications following mastectomy with reconstruction on breast cancer recurrence.
    Am J Surg. 2019;217:519.
    PubMed    



  53. The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2019;217:478.
    PubMed    


    January 2019
  54. CHATTERJEE A, Asban A, Jonczyk M, Chen L, et al
    A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer.
    Am J Surg. 2019 Jan 31. pii: S0002-9610(18)31174.
    PubMed     Abstract available


  55. SATYANANDA V, Ozao-Choy J, Dauphine C, Chen KT, et al
    Effect of the Affordable Care Act on breast cancer presentation at a safety net hospital.
    Am J Surg. 2019 Jan 17. pii: S0002-9610(18)31369.
    PubMed     Abstract available


    November 2018
  56. BURKHEIMER E, Starks L, Khan M, Oostendorp L, et al
    The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2018 Nov 14. pii: S0002-9610(18)30972.
    PubMed     Abstract available


    October 2018
  57. VALENTE SA, Liu Y, Upadhyaya S, Tu C, et al
    The effect of wound complications following mastectomy with immediate reconstruction on breast cancer recurrence.
    Am J Surg. 2018 Oct 16. pii: S0002-9610(18)31027.
    PubMed     Abstract available


    September 2018
  58. PUGH AM, Giannini CM, Pinney SM, Hanseman DJ, et al
    Characteristics and diagnosis of pregnancy and lactation associated breast cancer: Analysis of a self-reported regional registry.
    Am J Surg. 2018 Sep 20. pii: S0002-9610(18)30115.
    PubMed     Abstract available


    August 2018
  59. WAZIR U, Mokbel L, Wazir A, Mokbel K, et al
    Optimizing adjuvant endocrine therapy for early ER+ breast cancer: An update for surgeons.
    Am J Surg. 2018 Aug 3. pii: S0002-9610(18)30269.
    PubMed     Abstract available


    July 2018
  60. NAYYAR A, Strassle PD, Shen MR, Black JA, et al
    Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
    Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30024.
    PubMed     Abstract available


  61. SCHWARTZBERG BS, Chin DT, Dorn PL, Herron DS, et al
    Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
    Am J Surg. 2018 Jul 19. pii: S0002-9610(18)30097.
    PubMed     Abstract available


  62. PARVEZ E, Cornacchi SD, Fu E, Hodgson N, et al
    Adoption and outcomes of radioguided seed localization for non-palpable invasive and in-situ breast cancer at three academic tertiary care centers.
    Am J Surg. 2018 Jul 9. pii: S0002-9610(18)30445.
    PubMed     Abstract available


    April 2018
  63. PARK VY, Kim EK, Moon HJ, Yoon JH, et al
    Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
    Am J Surg. 2018 Apr 21. pii: S0002-9610(17)31185.
    PubMed     Abstract available


  64. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2018;215:693-698.
    PubMed     Abstract available


  65. KOZICK Z, Hashmi A, Dove J, Hunsinger M, et al
    Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment.
    Am J Surg. 2018;215:686-692.
    PubMed     Abstract available


    March 2018
  66. MASSIMINO K
    Discussion of: "Pre-surgical chemotherapy for breast cancer may be associated with improved outcome".
    Am J Surg. 2018 Mar 20. pii: S0002-9610(17)31659.
    PubMed    


  67. JOHNSON N
    Discussion of: Routine shave margins are not necessary in early stage breast cancer treated with breast conserving surgery.
    Am J Surg. 2018 Mar 20. pii: S0002-9610(18)30404.
    PubMed    


  68. COOK M, Johnson N
    Pre-surgical chemotherapy for breast cancer may be associated with improved outcomes.
    Am J Surg. 2018 Mar 16. pii: S0002-9610(17)31537.
    PubMed     Abstract available


  69. WILSON LL
    LaSalle D. Leffall and disparities in breast cancer.
    Am J Surg. 2018 Mar 7. pii: S0002-9610(18)30343.
    PubMed    



  70. Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2018;215:513-514.
    PubMed    



  71. Discussion of: A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:404-405.
    PubMed    


  72. KUPSTAS A, Ibrar W, Hayward RD, Ockner D, et al
    A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:400-403.
    PubMed     Abstract available


    February 2018
  73. WARREN SL, Bhutiani N, Agle SC, Martin RCG 2nd, et al
    Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer.
    Am J Surg. 2018 Feb 17. pii: S0002-9610(17)31373.
    PubMed     Abstract available


  74. DEBARROS M
    The significance and impact of pathogenic and variants of unknown significance (VUS) mutations in breast cancer patients and their treatment decisions.
    Am J Surg. 2018 Feb 15. pii: S0002-9610(17)31692.
    PubMed    


  75. HENRY-TILLMAN RS
    The tale of two stories: Challenges and innovations in breast cancer management.
    Am J Surg. 2018 Feb 1. pii: S0002-9610(17)31767.
    PubMed     Abstract available


    January 2018
  76. PAJAK C, Pao J, Ghuman A, McKevitt EC, et al
    Routine shave margins are not necessary in early stage breast cancer treated with Breast Conserving Surgery.
    Am J Surg. 2018 Jan 16. pii: S0002-9610(17)31640.
    PubMed     Abstract available


  77. SUTTON T, Reilly P, Johnson N, Garreau JR, et al
    Breast cancer in women under 50: Most are not high risk.
    Am J Surg. 2018 Jan 11. pii: S0002-9610(17)31563.
    PubMed     Abstract available


  78. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    PubMed     Abstract available


  79. RHEE D, Pockaj B, Wasif N, Stucky CC, et al
    Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Am J Surg. 2018;215:151-154.
    PubMed     Abstract available


    December 2017
  80. HEELAN GLADDEN AA, Sams S, Gleisner A, Finlayson C, et al
    Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines.
    Am J Surg. 2017;214:1104-1109.
    PubMed     Abstract available


  81. VELAZCO CS, Wasif N, Pockaj BA, Gray RJ, et al
    Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve.
    Am J Surg. 2017;214:1091-1093.
    PubMed     Abstract available


  82. CHANG JM, Kosiorek HE, Wasif N, Gray RJ, et al
    The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.
    Am J Surg. 2017;214:1096-1101.
    PubMed     Abstract available


    November 2017
  83. TSUNG K, Grobmyer SR, Tu C, Abraham J, et al
    Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2017 Nov 14. pii: S0002-9610(17)30998.
    PubMed     Abstract available


  84. QU LT, Peters S, Cobb AN, Godellas CV, et al
    Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment.
    Am J Surg. 2017 Nov 13. pii: S0002-9610(17)31018.
    PubMed     Abstract available


    October 2017
  85. ABBOTT AM, Valente SA, Loftus L, Tendulkar RD, et al
    A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
    Am J Surg. 2017;214:629-633.
    PubMed     Abstract available


  86. BUCKLEY EJ, Zahnd WE, Rea DJ, Mellinger JD, et al
    Impact of rural-urban status on survival after mastectomy without reconstruction versus mastectomy with reconstruction.
    Am J Surg. 2017;214:645-650.
    PubMed     Abstract available


  87. NURUDEEN S, Guo H, Chun Y, Coopey S, et al
    Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Am J Surg. 2017;214:687-694.
    PubMed     Abstract available


    September 2017
  88. CHAGPAR A
    Discussion of Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 30. pii: S0002-9610(17)31379.
    PubMed    


  89. CHAGPAR AB
    On baseball and breast cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31086.
    PubMed     Abstract available


  90. CHAGPAR AB, Horowitz N, Sanft T, Wilson LD, et al
    Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30420.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: